Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers
about
New viruses for cancer therapy: meeting clinical needsInitial testing of the replication competent Seneca Valley virus (NTX-010) by the pediatric preclinical testing programPreclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and ValidationOncolytic virus therapy for glioblastoma multiforme: concepts and candidatesTrial Watch:: Oncolytic viruses for cancer therapyOncolytic Seneca Valley Virus: past perspectives and future directionsStructure of Seneca Valley Virus-001: An Oncolytic Picornavirus Representing a New GenusOncolytic virotherapy for pediatric malignancies: future prospectsCrystallization and preliminary X-ray diffraction studies of Seneca Valley virus-001, a new member of the Picornaviridae family.Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1Adenovirus gene therapy for pediatric cancers: shall we gather at the liver?Novel systemic therapies for small cell lung cancerOncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.Oncolytic viruses: From bench to bedside with a focus on safety.A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen.Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.Structural features of the Seneca Valley virus internal ribosome entry site (IRES) element: a picornavirus with a pestivirus-like IRESGeneration and diagnostic application of monoclonal antibodies against Seneca Valley virus.Targeting pediatric cancer stem cells with oncolytic virotherapyA single intravenous injection of oncolytic picornavirus SVV-001 eliminates medulloblastomas in primary tumor-based orthotopic xenograft mouse models.Gene therapy progress and prospects cancer: oncolytic viruses.Oncolytic bluetongue viruses: promise, progress, and perspectivesPhase I trial of Seneca Valley Virus (NTX-010) in children with relapsed/refractory solid tumors: a report of the Children's Oncology Group.Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products.Cytolytic replication of echoviruses in colon cancer cell linesEffective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug TherapyRapid actin-dependent viral motility in live cellsReal-Time Reverse Transcription PCR Assay for Detection of Senecavirus A in Swine Vesicular Diagnostic Specimens.The multi-systemic nature of diabetes mellitus: Genotype or phenotype?Novel therapeutic approaches for small cell lung cancer: the future has arrivedOncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.A novel RNA-based in situ hybridization to detect Seneca Valley virus in neonatal piglets and sows affected with vesicular disease.Detection of the Emerging Picornavirus Senecavirus A in Pigs, Mice, and Houseflies.Trial watch: Oncolytic viruses for cancer therapySelective tropism of Seneca Valley virus for variant subtype small cell lung cancer.Past, present and future of therapies in pediatric sarcomas.Use of attenuated paramyxoviruses for cancer therapy.Clinical development directions in oncolytic viral therapy.Non-human viruses developed as therapeutic agent for use in humans.
P2860
Q24567699-7C34F0F9-80BF-4A93-B766-AB586DD678B1Q24627862-4CD49ECB-F242-4801-9F48-88D071CF3FD3Q26784048-C1245F83-BA01-4901-955A-EE59A4C10B83Q27007519-FEA8BC68-4630-411E-85DF-A9A7708D04AFQ27021951-E208674C-A364-412D-AB43-73C683D7C0DEQ27468763-1FAEC013-44D1-4EBD-9FC5-7057710EA801Q27652596-232D6274-7407-41A4-A18D-EFB0A460B73FQ28069358-D82759F4-7F93-486E-84A6-140B04F30B59Q31151631-D31D7704-0C76-47CB-A226-D0A75D6307BDQ33579883-D810B875-6207-4756-BB88-F51A9B143403Q33804100-651ECE76-E5CA-45BA-8C4D-EE15EBA908D6Q33862245-CCDE112C-3E79-4C0B-B1E4-17E16FB5B31EQ33906116-8A49E211-CA77-40A0-AE86-5E0128BCC5EBQ34044071-76A16DCC-72E9-4B59-B3AA-CB1C325E11E9Q34113916-AE6F7EA6-6C69-4A91-A3FB-C819B8DF4026Q34163338-8186AE78-6268-4A3C-92CA-935955D71B03Q34164918-5BC5B7D5-B7C1-4DAE-9E54-BD7EE550047AQ34256718-A795CED6-9E63-4A9C-8A29-FE48BF4E9610Q34262327-FBD4D688-95FC-4ADE-9EAA-8CCC4DC13208Q34480521-AAC3DD20-10E2-4254-9E69-B04E7A3F24ACQ34770611-D95A55D0-9CCA-4FA2-8543-8E0ED5F91FE5Q35084491-E863F290-60C2-4C86-B8DA-40056C4C41B7Q35224606-D433FE9F-76AC-4FDD-8D07-088C8C70A9B0Q35501324-26664568-9B34-4BA6-BCB4-FF8259EB3677Q35541517-A76E1CE4-1928-406C-BBDF-147D9B747F70Q35561280-7AC6D6AA-7D09-46E9-AA19-84AC3E636A5AQ35662216-4E62E99A-6995-4667-9681-DE199E3F1AF1Q35815781-136D0111-A3D3-4641-9F73-7FDCA5AB1E2EQ35891677-CBCCE686-B539-46AA-95DF-A89FCE779188Q35919282-E669398C-FCCD-4127-BE89-E75DAD3E4848Q36084288-F329ADA2-4B58-4C7D-9C88-0119FF8CA135Q36099082-F107C94D-2350-4F0E-859B-3ACEF1D32D84Q36342109-A17C6456-B921-4DD7-867D-7951B58C2F39Q36933198-C6042C99-3B02-4084-A79C-865870527FE9Q37028023-9CC863E5-0314-4D7B-A749-EE8E1439ADA1Q37463325-9D509331-D389-497F-A379-71D0C8CA1186Q37725915-A3B690B9-E741-4F80-8568-8305676ABB1AQ37810599-D2867EB8-C4C8-4110-8ECF-ADB406A11A63Q37857659-E23CECE5-E1D0-4A37-BA65-6FF2FCE82229Q37874215-9CC81FBF-C076-4BDC-A698-B4BE536D19FC
P2860
Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@ast
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@en
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@nl
type
label
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@ast
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@en
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@nl
prefLabel
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@ast
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@en
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@nl
P2093
P2860
P356
P1476
Seneca Valley virus, a systemi ...... ment of neuroendocrine cancers
@en
P2093
Ann-Jeanette Vasko
D Neil Watkins
Jingping Yang
Kevin D Burroughs
Kristine L Skele
Laura M Hales
Neeraja Idamakanti
P Seshidhar Reddy
Paul L Hallenbeck
P2860
P304
P356
10.1093/JNCI/DJM198
P407
P577
2007-10-30T00:00:00Z